Gabriela Balikova Novotna

Dr. Gabriela Balikova Novotna


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2006 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
JJJ. Janata
J. Janata
We found a new variant of the streptogramin A resistance gene, vga (A) LC , in clinical isolates of Staphylococcus haemolyticus resistant to lincomycin and clindamycin but susceptible to erythromycin and in which no relevant lincosamide resistance gene was detected. The gene vga (A) LC , differing from the gene vga (A) at the protein level by seven amino acid substitutions, was present exclusively in S. haemolyticus strains resistant to both lincosamides and streptogramin A (LS A phenotype). Antibiotic resistance profiles of the ATP-binding cassette (ABC) proteins Vga(A) LC and Vga(A) in the antibiotic-susceptible host S. aureus RN4220 were compared. It was shown that Vga(A) LC conferred resistance to both lincosamides and streptogramin A, while Vga(A) conferred significant resistance to streptogramin A only. Detailed analysis of the seven amino acid substitutions, distinguishing the two related ABC proteins with different substrate specificities, identified the substrate-recognizing site: four clustered substitutions (L212S, G219V, A220T, and G226S) in the spacer between the two ATP-binding cassettes altered the substrate specificity and constituted the lincosamide-streptogramin A resistance phenotype. A transport experiment with radiolabeled lincomycin demonstrated that the mechanism of lincosamide resistance in S. haemolyticus was identical to that of the reported macrolide-streptogramin B resistance conferred by Msr(A).

1 February 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JLJakub Lenart
Jakub Lenart
VVVladimir Vimberg
Vladimir Vimberg
LVLudmila Vesela
Ludmila Vesela
JJJiri Janata
Jiri Janata
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
Detailed mutational analysis examines the roles of individual residues of the Vga(A) linker in determining the antibiotic resistance phenotype. It defines a narrowed region of residues 212 to 220 whose composition determines the resistance specificity to lincosamides, pleuromutilins, and/or streptogramins A. From the analogy with the recently described function of the homologous ABC-F protein EttA as a translational factor, we infer that the Vga(A) linker interacts with the ribosome and directly or indirectly affects the binding of the respective antibiotic.

26 October 2021 in mBio
Verified
Journal Article
Open access
MKMarketa Koberska
Marketa Koberska
LVLudmila Vesela
Ludmila Vesela
VVVladimir Vimberg
Vladimir Vimberg
JLJakub Lenart
Jakub Lenart
JVJana Vesela
Jana Vesela
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
Resistance proteins are perceived as mechanisms protecting bacteria from the inhibitory effect of their produced antibiotics or antibiotics from competitors. Here, we report that antibiotic resistance proteins regulate lincomycin biosynthesis in response to subinhibitory concentrations of antibiotics.

3 April 2020 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
VVVladimir Vimberg
Vladimir Vimberg
LZLeona Zieglerová
Leona Zieglerová
KBKarolína Buriánková
Karolína Buriánková
PBPavel Branny
Pavel Branny
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
vanZ, a member of the VanA glycopeptide resistance gene cluster, confers resistance to lipoglycopeptide antibiotics independent of cell wall precursor modification by the vanHAX genes. Orthologs of vanZ are present in the genomes of many clinically relevant bacteria, including Enterococcus faecium and Streptococcus pneumoniae; however, vanZ genes are absent in Staphylococcus aureus. Here, we show that the expression of enterococcal vanZ paralogs in S. aureus increases the minimal inhibitory concentrations of lipoglycopeptide antibiotics teicoplanin, dalbavancin, oritavancin and new teicoplanin pseudoaglycone derivatives. The reduction in the binding of fluorescently labeled teicoplanin to the cells suggests the mechanism of VanZ-mediated resistance. In addition, using a genomic vanZ gene knockout mutant of S. pneumoniae, we have shown that the ability of VanZ proteins to compromise the activity of lipoglycopeptide antibiotics by reducing their binding is a more general feature of VanZ-superfamily proteins.

20 October 2020 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
VVVladimir Vimberg
Vladimir Vimberg
JCJorunn Pauline Cavanagh
Jorunn Pauline Cavanagh
MNMichaela Novotna
Michaela Novotna
JLJakub Lenart
Jakub Lenart
BNBich Nguyen Thi Ngoc
Bich Nguyen Thi Ngoc
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
Vga(A) protein variants confer different levels of resistance to lincosamides, streptogramin A, and pleuromutilins (LS A P) by displacing antibiotics from the ribosome. Here, we show that expression of vga (A) variants from Staphylococcus haemolyticus is regulated by cis -regulatory RNA in response to the LS A P antibiotics by the mechanism of ribosome-mediated attenuation. The specificity of induction depends on Vga(A)-mediated resistance rather than on the sequence of the riboregulator.

8 August 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
RDRahul Deb
Rahul Deb
MTMarcelo D. T. Torres
Marcelo D. T. Torres
MBMiroslav Boudný
Miroslav Boudný
MKMarkéta Koběrská
Markéta Koběrská
FCFloriana Cappiello
Floriana Cappiello
RVRobert Vácha
Robert Vácha
Peptides that form transmembrane barrel-stave pores are potential alternative therapeutics for bacterial infections and cancer. However, their optimization for clinical translation is hampered by a lack of sequence-function understanding. Recently, we have de novo designed the first synthetic barrel-stave pore-forming antimicrobial peptide with an identified function of all residues. Here, we systematically mutate the peptide to improve pore-forming ability in anticipation of enhanced activity. Using computer simulations, supported by liposome leakage and atomic force microscopy experiments, we find that pore-forming ability, while critical, is not the limiting factor for improving activity in the submicromolar range. Affinity for bacterial and cancer cell membranes needs to be optimized simultaneously. Optimized peptides more effectively killed antibiotic-resistant ESKAPEE bacteria at submicromolar concentrations, showing low cytotoxicity to human cells and skin model. Peptides showed systemic anti-infective activity in a preclinical mouse model of Acinetobacter baumannii infection. We also demonstrate peptide optimization for pH-dependent antimicrobial and anticancer activity.